Regeneron Pharmaceuticals, Inc.


REGN

Price

594.8


Change

-7.6


High

NA


Low

NA


Avg Volume

880,214


PE Ratio

8.46


52 Week High

747.42


52 Week Low

536.08



Profile

Regeneron Pharmaceuticals, Inc. is an American biotechnology company headquartered in Tarrytown, New York. The company was founded in 1988. Originally focused on neurotrophic factors and their regenerative capabilities , it branched out into the study of both cytokine and tyrosine kinase receptors. Regeneron has developed aflibercept, a VEGF inhibitor, and rilonacept, an interleukin-1 blocker. VEGF is a protein that normally stimulates the growth of blood vessels, and interleukin-1 is a protein that is normally involved in inflammation.


Top Streaming News


Quotes delayed 15 minutes for NASDAQ, and 20 minutes for NYSE and AMEX.

Data provided by IEX Cloud

About

Copyright © 2020 Finaza.IO. All Rights Reserved.